Favipiravir for Anti Virus Drugs 259793-96-9

China Favipiravir for Anti Virus Drugs 259793-96-9, Find details about China Anti Virus Drugs, T-705 from Favipiravir for Anti Virus Drugs 259793-96-9

Model NO.
Favipiravir
Active Ingredient
T-705
Appearance
White Powder
Test Method
HPLC
CAS No.
259793-96-9
Molecular Formula
C21h31o2
Molecular Weight
314.45
Extraction
Solvent Extraction
Function
Antiviral Agent
Place of Source
Organic Hemp Seeds
Storage
Store in a Cool and Dry Place
Shelf Life
2 Years
Free Sample
1 Gram Available
Boilling Point
609.2 ºC at 760 Mmhg
Trademark
Zebrago
Transport Package
Drum
Specification
99.9%
Origin
China
HS Code
2932999099
Model NO.
Favipiravir
Active Ingredient
T-705
Appearance
White Powder
Test Method
HPLC
CAS No.
259793-96-9
Molecular Formula
C21h31o2
Molecular Weight
314.45
Extraction
Solvent Extraction
Function
Antiviral Agent
Place of Source
Organic Hemp Seeds
Storage
Store in a Cool and Dry Place
Shelf Life
2 Years
Free Sample
1 Gram Available
Boilling Point
609.2 ºC at 760 Mmhg
Trademark
Zebrago
Transport Package
Drum
Specification
99.9%
Origin
China
HS Code
2932999099

Favipiravir for Anti Virus Drugs 259793-96-9
Product name:Favipiravir 
Appearance:White powder
CAS:259793-96-9
Purity:98%min(HPLC)

Faveravir, also known as T705, or Avigan, a new RNA dependent RNA polymerase (RdRp) inhibitor, belongs to a broad-spectrum anti influenza virus drug, which is used to treat new and recurrent influenza.

 

Fabiravir is a new broad-spectrum anti RNA virus drug, and virus  belongs to RNA single stranded virus. In addition to influenza virus, the drug also showed good antiviral effect on a variety of RNA viruses, such as Ebola virus, sand virus, Bunia virus, rabies virus, etc


Favipiravir for Anti Virus Drugs 259793-96-9

As a new broad-spectrum anti RNA virus drug, favipiravir was approved for marketing in Japan in March 2014 and used for antiviral treatment of influenza A and B. In addition to the influenza virus, the drug also showed good antiviral activity to a variety of RNA viruses, such as  sand virus, Bunia virus, rabies virus, etc. 


Favipiravir for Anti Virus Drugs 259793-96-9

Product NameFavipiravir
Batch NumberZ20180901
Production Date2018.9. 3
Batch Quantity24000G
Analysis Date2018.9. 4
Expiry Date2020.9. 2
Certificate Date2018.9. 15
ItemTest StandardTesting Result
CBDNot less than (NLT) 99.5% 99.9%
THCNot detectedUndetected
AssayMethod HPLC calculated on the anhydrous basis limit of quotation (LOQ) 0.8ppm
AppearanceWhite powderWhite  powder
IdentificationIn the recorded chromatograms under the determination of the substance, retention time of the main peak of the solution should be consistent with the retention of time of the main peak of the reference solutionComplies
Melting Point65~66ºC65.5ºC
Loss on DryingNMT 1.0%0.21%
Residual solventsEthanol NMT 400ppm
Heptane NMT 400ppm
1.92ppm
256.0ppm
Heavy MentalNMT 20ppmComplies
Microbial Limite TestMethod: Plate Counting  
Total aerobic bacteria countNMT 1000cfu/gComplies
Combined molds and yeastNMT 100cfu/gComplies
E. ColiNot detacted per gramComplies
SalmanellaNot detacted per 10 gramComplies
Conclusion: Conform the testing result is qualified

Storage: Closed container. Dry & cool. Keep away from moisture &strong light
Shelf life: 24 Months


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9


Favipiravir for Anti Virus Drugs 259793-96-9